OMNISPIRANT
OmniSpirant develops regenerative gene therapies with the potential to transform respiratory medicine.
OMNISPIRANT
Industry:
Biotechnology Medical
Founded:
2016-01-01
Address:
Tipperary, Tipperary, Ireland
Country:
Ireland
Website Url:
http://www.omnispirant.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
71.43 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network GStatic Google Static Content Wix
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - OmniSpirant
Official Site Inspections
http://www.omnispirant.com
- Host name: lh41.dnsireland.com
- IP address: 185.43.232.207
- Location: Ireland
- Latitude: 53.3472
- Longitude: -6.2439
- Timezone: Europe/Dublin
More informations about "OmniSpirant"
Exosome Gene Therapy - Omnispirant
OmniSpirant Limited has received funding from the European Union’s Horizon 2020 research and innovation programme under SME Instrument grant agreement 855463_ReSpire and under …See details»
About - Omnispirant
OmniSpirant Limited was founded by Gerry McCauley in 2016. Gerry qualified as a Master of Pharmacy in 2001. Gerry has extensive commercial knowledge, industry contacts and has …See details»
OmniSpirant - Crunchbase Company Profile & Funding
When was the last funding round for OmniSpirant? OmniSpirant closed its last funding round on Jan 1, 2019 from a Grant round. Who are OmniSpirant 's competitors? Alternatives and …See details»
OmniSpirant - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
OmniSpirant Company Profile - Office Locations, Competitors
OmniSpirant is a company that develops inhaled regenerative gene therapy for cystic fibrosis and other lung diseases such as COPD (chronic obstructive pulmonary disease). It is based on the …See details»
OmniSpirant Limited - LinkedIn
OmniSpirant Limited | 683 followers on LinkedIn. Changing the paradigm of treatment for cancer and respiratory disease. | OmniSpirant Limited is an early stage therapeutics company based …See details»
OmniSpirant - Products, Competitors, Financials, Employees ...
About OmniSpirant Therapeutics: OmniSpirant is an Irish biotech founded in 2016 to develop first-in-class inhaled regenerative gene therapies. The OmniSome platform of products are …See details»
Emily's Entourage » Emily’s Entourage Awards $220,000 Research …
Feb 14, 2023 Emily’s Entourage Awards $220,000 Research Grant to Queen’s University Belfast to Support the Development of OmniSpirant Limited’s Novel Regenerative Gene Therapy for …See details»
OmniSpirant Limited launch new gene therapy treatment project
Dec 2, 2022 OmniSpirant Limited was founded in 2016 by Mr Gerry McCauley, a pharmacist and inventor of the inhaled surface-engineered EV platform technology (OmniSomesâ„¢). …See details»
OmniSpirant - Contacts, Employees, Board Members, Advisors
OmniSpirant develops regenerative gene therapies with the potential to transform respiratory medicine.See details»
OmniSpirant - Funding, Financials, Valuation & Investors
OmniSpirant develops regenerative gene therapies with the potential to transform respiratory medicine. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
OmniSomes Regenerative Gene Therapies - Omnispirant
Technology Omnispirant 2024-08-20T15:16:14+01:00. Developing OmniSomes as First-in-Class Regenerative Gene Therapies. A novel inhaled stem cell Extracellular Vesicle (exosome) …See details»
A new way of treating cystic fibrosis | ReSpire Project - CORDIS
Jan 17, 2020 For the first time, OmniSpirant has demonstrated the widespread and efficient entry into the high number of cells required for truly successful CF gene therapy. “OmniSpirant …See details»
Omnispirant explores Inhaled Gene Therapy
Mar 11, 2021 StartUs insights analysis of the global respiratory drug development landscape highlights OmniSpirant’s inhaled regenerative gene therapy platform: Omnispirant explores …See details»
OmniSpirant and EVerZom Team up to Develop a New Gene …
Dec 8, 2022 OmniSpirant Limited and EVerZom are delighted to announce the launch of INSPIRE, a €12.8 million lung cancer project funded by Horizon Europe. The project gathers …See details»
OmniSpirant and EVerZom Team up to Develop a New Gene …
Dec 6, 2022 A €12.8 million lung cancer project funded by Horizon EuropePARIS--(BUSINESS WIRE)--OmniSpirant Limited and EVerZom are delighted to announce the launch of INSPIRE, …See details»
OmniSpirant Limited Announces the Launch of INSPIRE; an EU …
Dec 14, 2022 PRESS RELEASE OmniSpirant Limited are delighted and honoured to announce the launch of INSPIRE, a €12.8 million lung cancer project funded by Horizon Europe. In one …See details»
OmniSpirant Limited and EVerZom Announce the Launch of
Dec 6, 2022 Galway, 25 th November 2022 –OmniSpirant Limited and EVerZom are delighted and honoured to announce the launch of INSPIRE, a €12.8 million lung cancer project funded …See details»
OmniSpirant - EU-Startups
OmniSpirant develops regenerative gene therapies with the potential to transform respiratory medicine.See details»
News - Omnispirant
OmniSpirant Limited has received funding from the European Union’s Horizon 2020 research and innovation programme under SME Instrument grant agreement 855463_ReSpire and under …See details»